InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,615.35
(
0.55%
)
US TECH 100
19,804.00
(
0.64%
)
Dow Jones
40,000.90
(
0.62%
)
Brent Oil
84.57
(
0.00%
)
Bitcoin
58,059.90
(
0.29%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biotech_researcher

Send PM Follow Ignore
Followers 84
Posts 12485
Boards Moderated 0
Alias Born 07/25/2008

biotech_researcher

Re: None

Wednesday, 02/13/2013 8:52:14 PM

Wednesday, February 13, 2013 8:52:14 PM

Post# of 80490
Well, I'm puzzled by this excitement on a potential "next molecule". I sure hope that everyone realizes that the start of a new trial for Ponatinib in the GIST indication, for example, is worth MUCH, MUCH more to the share price of Ariad than the start of a IND (which is not EVEN a phase 1/2 trial) for a new compound).. Tell me we are all on that side of the fence, right?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up